Concepedia

Hui Quan

HQ

57

Publications

10.5K

Citations

33

H-Index

1987

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Sanofi (United States)

United States Military Academy

Novartis (United States)

Rutgers, The State University of New Jersey

Hui Quan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, statistics, and clinical trials.

ORCID

Top concepts

Publications per year

1987–2020

57

Publications

57

Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial

Robert S. Bresalier, Robert S. Sandler, Hui Quan et al. · New England Journal of Medicine · 2005 · 2.5K citations · Full text

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

Uri Liberman, Stuart Weiss, Johann Bröll et al. · New England Journal of Medicine · 1995 · 2.3K citations

Effects of Specific Inhibition of Cyclooxygenase-2 on Sodium Balance, Hemodynamics, and Vasoactive Eicosanoids

Francesca Catella-Lawson, Brendan McAdam, Briggs Morrison et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 595 citations

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis

Loren Laine, S. E. Harper, Thomas Simon et al. · Gastroenterology · 1999 · 476 citations

, , +9

A Randomized Trial of Rofecoxib for the Chemoprevention of Colorectal Adenomas

John A. Baron, Robert S. Sandler, Robert S. Bresalier et al. · Gastroenterology · 2006 · 431 citations · Full text

, , +6

Rows per page

1–5 of 57